By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Teva Pharmaceutical Industries Limited 

5 Basel Street

Petach Tikva    49131  Israel
Phone: 972-3-9267-267 Fax: 972-3-9234-050


SEARCH JOBS


Industry
Biotechnology






Company News
Teva Pharmaceutical Industries Limited (TEVA) Announces FDA Approval Of QNASL® (Beclomethasone Dipropionate) Nasal Aerosol For Treatment Of Children With Seasonal And Perennial Allergic Rhinitis 12/19/2014 10:31:45 AM
Teva Pharmaceutical Industries Limited (TEVA) Provides 2015 Business Outlook 12/11/2014 7:53:06 AM
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of First Generic Celebrex® Capsules In The United States 12/10/2014 8:17:10 AM
Teva Pharmaceutical Industries Limited (TEVA) To Host 2015 Business Outlook Conference Call And Webcast On December 11, 2014 12/2/2014 3:04:42 PM
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of Generic Exforge HCT® Tablets In The United States 12/1/2014 12:52:07 PM
Prof. Yitzhak Peterburg Elected Chairman Of Teva Pharmaceutical Industries Limited (TEVA)’s Board Of Directors 11/26/2014 10:54:31 AM
IntelliPharmaCeutics Notes Launch Of 5mg Strength Of Focalin XR(R) Generic By Teva Pharmaceutical Industries Limited (TEVA) 11/20/2014 10:33:07 AM
Teva Pharmaceutical Industries Limited (TEVA) Launches Liquid Formulation Of TREANDA® (bendamustine HCI) Injection In U.S. 11/18/2014 12:31:29 PM
Teva Pharmaceutical Industries Limited (TEVA) Presents Positive Safety And Efficacy Data For QNASL® (Beclomethasone Dipropionate) Nasal Aerosol In Treating Children With Perennial Allergic Rhinitis 11/7/2014 10:54:43 AM
Teva Pharmaceutical Industries Limited (TEVA) Presents Data For Investigational Short-Acting Beta-Agonist Inhaler (Albuterol MDPI) At 2014 Annual Scientific Meeting Of The American College of Allergy, Asthma and Immunology (ACAAI) 11/7/2014 9:38:11 AM
12345678910...
//-->